Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001104659-25-034321

10% owner bought 934,258 shares at an average $10.13 ($9,464,512)

From the SEC's structured data for this filing

Trades in this filing

ADAR1 Capital Management, LLC · 10% owner

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-09 Purchase : show line 1 in the form +18,560 $9.40 $174,375 3,493,404 I
2025-04-09 Purchase : show line 2 in the form +16,365 $9.40 $153,752 743,558 I
2025-04-09 Purchase : show line 3 in the form +325,000 $9.86 $3,203,525 3,818,404 I
2025-04-09 Purchase : show line 4 in the form +500,000 $10.33 $5,165,000 4,318,404 I
2025-04-09 Purchase : show line 5 in the form +74,333 $10.33 $767,860 4,392,737 I
Open-market purchases · 934,258 sh · avg $10.13 · $9,464,512

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-04-09 Other disposition : show line 6 in the form Cash-Settled Total Return Swaps −325,000 624,333 I
2025-04-09 Other disposition : show line 7 in the form Cash-Settled Total Return Swaps −500,000 124,333 I
2025-04-09 Other disposition : show line 8 in the form Cash Settled Total Return Swaps −74,333 50,000 I
Loading xslF345X05/tm2512234-2_4seq1.xml…